Global ADME Toxicology Testing Market Growth (Status and Outlook) 2023-2029

Global ADME Toxicology Testing Market Growth (Status and Outlook) 2023-2029

ADME testing refers to the pharmacokinetic testing of a compound in living organism and known as ADME/Tox. Drug development is a cost and time intensive process. The traditional drug development process includes toxicity and efficacy testing in in-vivo environment which is responsible for late stage failure of drugs in human body, as the results observed in animal models and human are different. To overcome this drug failure hurdle drug manufacturers are incorporating ADME toxicity testing in early drug developmental phases.

LPI (LP Information)' newest research report, the “ADME Toxicology Testing Industry Forecast” looks at past sales and reviews total world ADME Toxicology Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected ADME Toxicology Testing sales for 2023 through 2029. With ADME Toxicology Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ADME Toxicology Testing industry.

This Insight Report provides a comprehensive analysis of the global ADME Toxicology Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on ADME Toxicology Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ADME Toxicology Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ADME Toxicology Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ADME Toxicology Testing.

The global ADME Toxicology Testing market size is projected to grow from US$ 4375.2 million in 2022 to US$ 8300.3 million in 2029; it is expected to grow at a CAGR of 9.6% from 2023 to 2029.

Geographically, North America is expected to have the largest market share in terms of revenue followed by Europe during the forecast period. Larger base of drug manufacturing organizations coupled with supportive government regulations pertaining to drug development are key drivers for the growth of this regional market. Additionally, increasing R&D investments related to drug discovery is also expected to propel growth of this market. Asia Pacific is expected to have a lucrative growth owing to rapidly improving healthcare infrastructure, rising spending in healthcare & diagnostic centers, increasing patient awareness levels and increased access to healthcare services in the emerging economies of India and China.

This report presents a comprehensive overview, market shares, and growth opportunities of ADME Toxicology Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Toxicology Testing
ADME Testing

Segmentation by application
In Vivo
In Vitro

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Accelrys (Dassault Systemes)
Agilent Technologies
Bio-Rad Laboratories
Promega
Sigma Aldrich
Thermo Fisher Scientific
Cyprtorex
CytoPulse
Entelos
LI-COR Biosciences
Mattek
Miltenyi Biotec
Molecular Toxicology
Quintiles
RTI Health Solutions
SBW
Xenobiotic Detection Systems
Xenometrix

Please note: The report will take approximately 2 business days to prepare and deliver.